ILC
iShares S&P/ASX 20 Etf
🇦🇺 ASX
NULL AUSTRALIA
NULL BETA
👑 Overview
📈 Performance
📙 Holdings
💰 Distributions
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💰
6.81%
Annual distribution yield
Based on the most recent distribution
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
23
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
ILC.AX was created on 2010-12-06 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 536.73m in AUM and 21 holdings. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of the 20 largest Australian securities listed on the ASX.
📈 Performance
Price History
+55.69%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show more
Updated as of 24 May 2023
Industry Exposure
🏦 Financials
35%
🧱 Materials
25%
📙 Other
22%
🩺 Health
11%
🔋 Energy
7%
Country Exposure
🇦🇺 Australia
99%
🇮🇪 Ireland
1%
🇺🇸 United States of America (the)
1%
💰 Distributions
Payouts
💰 Annual Distribution Yield*
6.81%
💰 Annual Distribution Earnings Per $1,000 invested**
$68.13
💰 Most Recent Distribution Franked Percentage Estimate
94.66%
💰 Average Distribution Franked Percentage Estimate
82.54 %
💰 Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.55
94.66%
2022
$1.92
26.93%
2021
$1.12
29.12%
2020
$0.75
25.21%
2019
$1.40
22.00%
2018
$1.14
26.85%
2017
$1.20
28.87%
2016
$1.33
28.14%
2015
$1.26
31.10%
💵 Costs
💼
0.24%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$27.79
💰 Price To Earnings Ratio
12.39
💰 Price To Book Ratio
2.18
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ILC
23
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in ILC
494 days
ILC investor breakdown
💵 Income of investors
More than 200k
11%
150k - 200k
100k - 150k
15%
50k - 100k
48%
Less than 50k
19%
👶 Age of investors
18 - 25
26 - 34
26%
35 - 90
74%
🙋 Legal gender of investors
Female
52%
Male
48%
Pearlers who invest in ILC also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
📊 Share price
$34.01 AUD
NULL US
NULL EX AUSTRALIA
NULL BETA
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
📊 Share price
$43.11 AUD
NULL US
NULL EX AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
📊 Share price
$104.08 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
Want more shares? Try these...
Iluka Resources Ltd. engages in the exploration, development, mining, processing, marketing, and rehabilitation of mineral sands products. The company is headquartered in Perth, Western Australia and currently employs 950 full-time employees. The Company’s principal activity is engaged in the exploration, development, mining, processing and marketing of minerals, and rehabilitation operations. The Company’s segments include Jacinth-Ambrosia/Mid West (JA/MW), Cataby/South West (C/SW) and United States/Murray Basin (US/MB). JA/MW segment comprises the mining operations at Jacinth-Ambrosia located in South Australia, and associated processing operations at the Narngulu mineral separation plant in mid-west Western Australia. C/SW segment comprises mining activities at Cataby and processing of ilmenite at Synthetic Rutile Kiln 2, both located in Western Australia. US/MB segment comprises rehabilitation obligations in the United States (Florida and Virginia) and certain idle assets located in Australia (Murray Basin). The company sells a range of titanium dioxide feedstocks, zircon products and rare earth minerals to customers in a variety of industries.
📊 Share price
$11.46 AUD
Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-04-13. The firm is engaged in drug research and repurposing. The company is focused on developing preventative or therapeutic drugs for viral infections. The firm's lead asset, ISLA-101 is developed by its subsidiary, Isla Pharmaceuticals. ISLA-101 is a drug with a safety profile, being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. The drug also has the potential to be used to prevent or treat a number of viruses including dengue, Zika and chikungunya, and other diseases rife in tropical climates. The firm is also considering alternative formulations, including a long-acting oral formulation and intravenous formulations for severe dengue infections. The firm's subsidiary is Isla Pharmaceuticals Inc.
📊 Share price
$0.13 AUD
ILB.AX was created on 2012-03-12 by iShares. The fund's investment portfolio concentrates primarily on investment grade fixed income. The fund aims to provide investors with the performance of the Bloomberg AusBond Inflation Government 0+ Yr Index, before fees and expenses. The index is designed to measure the performance of a segment of the Australian bond market comprised of inflation-linked fixed income securities.
📊 Share price
$125.34 AUD
NULL AUSTRALIA
NULL INCOME